By Kylie MacLellan and Ben Hirschler LONDON (Reuters) - British lawmakers intend to investigate U.S. drugmaker Pfizer's planned $100 billion takeover of British rival AstraZeneca in a bid to ensure scientific research and jobs are protected. "We will see how events pan out over the next few days, but clearly given the scale of the proposed merger it is important that we consider the impact not just on shareholders but also on employees and the wider interests of the UK." AstraZeneca, Britain's second-biggest drugmaker behind GlaxoSmithKline, is an important part of the life sciences sector and employs nearly 7,000 staff in the country. The committee's chairman Andrew Bailey said it would be looking to hold an inquiry "pretty quickly", and those called to give evidence were likely to include ministers such as Business Secretary Vince Cable and representatives from the Treasury. "In AstraZeneca we have a company that amounts to 2.3 percent of our total exports, is a world leader in research in pharmaceuticals and is very strategically positioned in this country." Committee member Katy Clark said Pfizer's management would also probably be among those called to any inquiry.
via Health News Headlines - Yahoo News http://ift.tt/1kqds8G
No comments:
Post a Comment